MRGAX vs. VGHCX

Last updated Jun 4, 2026

MRGAX (MFS Core Equity Fund) and VGHCX (Vanguard Health Care Fund Investor Shares) are both mutual funds - MRGAX is a Large Cap Blend Equities fund managed by MFS, while VGHCX is a Health & Biotech Equities fund managed by Vanguard. Over the past 10 years, MRGAX returned 14.22%/yr vs 8.79%/yr for VGHCX. A 0.76 correlation means they provide meaningful diversification when combined. MRGAX charges 0.93%/yr vs 0.30%/yr for VGHCX.

Performance

MRGAX vs. VGHCX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MFS Core Equity Fund (MRGAX) and Vanguard Health Care Fund Investor Shares (VGHCX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, MRGAX achieves a 8.17% return, which is significantly higher than VGHCX's -4.67% return. Over the past 10 years, MRGAX has outperformed VGHCX with an annualized return of 14.22%, while VGHCX has yielded a comparatively lower 8.79% annualized return.

MRGAX

• 1D: -0.17%
• 1M: 3.29%
• YTD: 8.17%
• 6M: 8.03%
• 1Y: 20.03%
• 3Y*: 17.77%
• 5Y*: 10.65%
• 10Y*: 14.22%

VGHCX

• 1D: -1.56%
• 1M: -1.40%
• YTD: -4.67%
• 6M: -4.29%
• 1Y: 16.18%
• 3Y*: 8.30%
• 5Y*: 7.16%
• 10Y*: 8.79%

*Multi-year figures are annualized to reflect compound growth (CAGR)

MRGAX vs. VGHCX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
MRGAX MFS Core Equity Fund	8.17%	12.33%	20.01%	22.88%	-17.24%	25.26%	18.56%	34.66%	-4.12%	23.79%
VGHCX Vanguard Health Care Fund Investor Shares	-4.67%	19.63%	8.99%	5.46%	-1.05%	14.36%	12.57%	22.93%	1.03%	19.59%

Correlation

The correlation between MRGAX and VGHCX is 0.47, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.47
Correlation (3Y) Calculated over the trailing 3-year period	0.55
Correlation (5Y) Calculated over the trailing 5-year period	0.65
Correlation (10Y) Calculated over the trailing 10-year period	0.69
Correlation (All Time) Calculated using the full available price history since Jan 2, 1996	0.76

Over the past year, the correlation between MRGAX and VGHCX has dropped to 0.47 - well below their long-term average of 0.76, suggesting their price drivers have been diverging.

Return for Risk

MRGAX vs. VGHCX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MRGAX

MRGAX Risk / Return Rank: 36
MRGAX Sharpe Ratio Rank: 36
MRGAX Sortino Ratio Rank: 34
MRGAX Omega Ratio Rank: 35
MRGAX Calmar Ratio Rank: 33
MRGAX Martin Ratio Rank: 43

VGHCX

VGHCX Risk / Return Rank: 17
VGHCX Sharpe Ratio Rank: 15
VGHCX Sortino Ratio Rank: 16
VGHCX Omega Ratio Rank: 14
VGHCX Calmar Ratio Rank: 22
VGHCX Martin Ratio Rank: 16

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MRGAX vs. VGHCX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for MFS Core Equity Fund (MRGAX) and Vanguard Health Care Fund Investor Shares (VGHCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	MRGAX	VGHCX	Difference
Sharpe ratio: Return per unit of total volatility	1.74	1.08	+0.66
Sortino ratio: Return per unit of downside risk	2.43	1.67	+0.76
Omega ratio: Gain probability vs. loss probability	1.31	1.19	+0.12
Calmar ratio: Return relative to maximum drawdown	2.18	1.73	+0.45
Martin ratio: Return relative to average drawdown	9.19	4.60	+4.59
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

MRGAX vs. VGHCX - Sharpe Ratio Comparison

The current MRGAX Sharpe Ratio is 1.74, which is higher than the VGHCX Sharpe Ratio of 1.08. The chart below compares the historical Sharpe Ratios of MRGAX and VGHCX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	MRGAX	VGHCX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.74	1.08	+0.66
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.64	0.40	+0.24
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.80	0.50	+0.30
Sharpe Ratio (All Time) Calculated using the full available price history	0.55	0.92	-0.38

Drawdowns

MRGAX vs. VGHCX - Drawdown Comparison

The maximum MRGAX drawdown since its inception was -54.04%, which is greater than VGHCX's maximum drawdown of -36.93%. Use the drawdown chart below to compare losses from any high point for MRGAX and VGHCX.

Drawdown Indicators

	MRGAX	VGHCX	Difference
Max Drawdown Largest peak-to-trough decline	-54.04%	-36.93%	-17.11%
Max Drawdown (1Y) Largest decline over 1 year	-9.53%	-9.20%	-0.33%
Max Drawdown (3Y) Largest decline over 3 years	-19.22%	-16.08%	-3.14%
Max Drawdown (5Y) Largest decline over 5 years	-23.08%	-16.95%	-6.13%
Max Drawdown (10Y) Largest decline over 10 years	-33.41%	-27.18%	-6.23%
Current Drawdown Current decline from peak	-0.17%	-7.61%	+7.44%
Average Drawdown Average peak-to-trough decline	-8.27%	-5.25%	-3.02%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.25%	3.44%	-1.19%

Volatility

MRGAX vs. VGHCX - Volatility Comparison

The current volatility for MFS Core Equity Fund (MRGAX) is 2.58%, while Vanguard Health Care Fund Investor Shares (VGHCX) has a volatility of 3.79%. This indicates that MRGAX experiences smaller price fluctuations and is considered to be less risky than VGHCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	MRGAX	VGHCX	Difference
Volatility (1M) Calculated over the trailing 1-month period	2.58%	3.79%	-1.21%
Volatility (6M) Calculated over the trailing 6-month period	9.16%	10.35%	-1.19%
Volatility (1Y) Calculated over the trailing 1-year period	11.94%	14.75%	-2.81%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.78%	18.21%	-1.43%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	17.80%	17.64%	+0.16%

MRGAX vs. VGHCX - Expense Ratio Comparison

MRGAX has a 0.93% expense ratio, which is higher than VGHCX's 0.30% expense ratio.

Dividends

MRGAX vs. VGHCX - Dividend Comparison

MRGAX's dividend yield for the trailing twelve months is around 12.57%, more than VGHCX's 6.93% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
MRGAX MFS Core Equity Fund	12.57%	13.60%	8.21%	2.54%	3.83%	7.28%	1.54%	3.20%	11.09%	6.27%	3.65%	11.02%
VGHCX Vanguard Health Care Fund Investor Shares	6.93%	6.00%	22.72%	7.17%	5.44%	8.31%	7.96%	11.82%	9.10%	7.30%	8.54%	8.16%

Frequently Asked Questions

Can I hold both MRGAX and VGHCX in my portfolio?

MRGAX and VGHCX have a correlation of 0.47, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, MRGAX or VGHCX?

VGHCX has higher volatility (3.79%) compared to MRGAX (2.58%). In terms of maximum drawdown, MRGAX dropped -54.04% vs VGHCX's -36.93%.

Which has better risk-adjusted returns?

MRGAX currently has the higher Sharpe Ratio (1.74 vs 1.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.